Skip to main content
Translational Pharmaceutics®

Quotient Sciences speaks with Outsourcing Pharma on what's ahead for CPhI

This article from Outsourcing Pharma describes how our team at Quotient Sciences is looking forward to reconnecting with customers and giving them a preview of how we are looking to expand Translational Pharmaceutics further within the US at CPhI North America.

Topics discussed include how we plan to stay ahead of industry trends and developments, recent partnerships and collaborations, challenges we are facing and how these are being addressed, future expansion plans, and insight into what sets us apart from industry competitors.

Read the full article here on the Outsourcing Pharma website.

Latest news from Quotient Sciences

More News
News & Announcements, Artificial Intelligence, Translational Pharmaceutics®, Formulation Development Quotient Sciences shortlisted for "Best Use of AI in Clinical Development & Trial Innovation" at the Scrip Awards 2026 By: Dr. Andrew Lewis
Read More
News & Announcements, Nottingham, UK, Artificial Intelligence, Translational Pharmaceutics®, Formulation Development Quotient Sciences Proprietary AI-Enhanced Solution Optimizes Formulation in Clinical Study By: Dr. Andrew Lewis
Read More
Let's Talk
Your breakthrough therapy deserves momentum, and every day matters. Start a conversation with us today.